Scarica l'app Stockscreener
26.73
1.66%
-0.45
Dopo l'orario di chiusura:
26.20
-0.53
-1.98%
Precedente Chiudi:
$27.18
Aprire:
$27.19
Volume 24 ore:
773.69K
Relative Volume:
1.21
Capitalizzazione di mercato:
$1.20B
Reddito:
$681.75M
Utile/perdita netta:
$70.47M
Rapporto P/E:
18.43
EPS:
1.45
Flusso di cassa netto:
$173.19M
1 W Prestazione:
-0.45%
1M Prestazione:
+16.52%
6M Prestazione:
+13.60%
1 anno Prestazione:
+76.55%
Intervallo 1D:
$26.52
$27.64
Intervallo di 1 settimana:
$26.17
$27.64
Portata 52W:
$12.61
$27.98
Pacira Biosciences Inc Stock (PCRX) Company Profile
Nome
Pacira Biosciences Inc
Settore
Telefono
650-242-8052
Indirizzo
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Confronta PCRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PCRX
Pacira Biosciences Inc
|
26.73 | 1.22B | 681.75M | 70.47M | 173.19M | 1.45 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-25 | Aggiornamento | Truist | Hold → Buy |
| 2025-01-30 | Aggiornamento | Truist | Sell → Hold |
| 2024-08-13 | Downgrade | Truist | Buy → Sell |
| 2024-08-12 | Downgrade | JP Morgan | Overweight → Underweight |
| 2024-08-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-08-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-08-12 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-07-03 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-03-07 | Ripresa | JP Morgan | Overweight |
| 2023-12-20 | Iniziato | Raymond James | Outperform |
| 2023-08-03 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-01-31 | Ripresa | Wedbush | Outperform |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-01-03 | Ripresa | JP Morgan | Overweight |
| 2021-07-26 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-04-21 | Ripresa | JP Morgan | Neutral |
| 2021-04-09 | Iniziato | Berenberg | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-02-11 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2021-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-09-21 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-07-06 | Reiterato | Needham | Buy |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-04-07 | Iniziato | Northland Capital | Outperform |
| 2020-03-20 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-02-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-01-24 | Iniziato | SunTrust | Buy |
| 2020-01-23 | Iniziato | SunTrust | Buy |
| 2019-11-06 | Iniziato | BTIG Research | Buy |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-05-06 | Aggiornamento | Mizuho | Underperform → Neutral |
| 2019-05-02 | Aggiornamento | Stifel | Sell → Hold |
| 2019-02-01 | Downgrade | Mizuho | Neutral → Underperform |
| 2018-08-06 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-21 | Reiterato | Mizuho | Neutral |
| 2018-02-16 | Downgrade | Needham | Buy → Hold |
| 2018-01-19 | Iniziato | Seaport Global Securities | Buy |
| 2018-01-04 | Reiterato | Canaccord Genuity | Buy |
| 2018-01-03 | Iniziato | Leerink Partners | Mkt Perform |
Mostra tutto
Pacira Biosciences Inc Borsa (PCRX) Ultime notizie
Does Pacira BioSciences Inc. have declining or rising EPSJuly 2025 Snapshot & Verified Momentum Stock Watchlist - khodrobank.com
Reversal indicators forming on Pacira BioSciences Inc. stockQuarterly Portfolio Summary & Daily Stock Trend Watchlist - Newser
What data driven models say about Pacira BioSciences Inc.’s futureWeekly Trade Summary & Safe Entry Momentum Tips - Newser
Pacira BioSciences Inc. stock prediction for this weekEarnings Recap Summary & Community Supported Trade Ideas - Newser
Visual trend scoring systems applied to Pacira BioSciences Inc.Quarterly Profit Report & AI Based Buy/Sell Signal Reports - Newser
Candlestick signals on Pacira BioSciences Inc. stock todayShare Buyback & Verified Trade Idea Suggestions - Newser
Has Pacira BioSciences Inc. formed a bullish divergenceJuly 2025 Spike Watch & Community Consensus Trade Signals - Newser
Published on: 2025-09-03 02:53:04 - Newser
Published on: 2025-09-03 02:13:24 - Newser
Chart based exit strategy for Pacira BioSciences Inc.Weekly Profit Analysis & Community Verified Watchlist Alerts - Newser
How to forecast Pacira BioSciences Inc. trends using time seriesJuly 2025 Levels & Risk Controlled Daily Plans - Newser
Live market analysis of Pacira BioSciences Inc.Weekly Trend Report & AI Powered Market Entry Strategies - Newser
Does Pacira BioSciences Inc. have strong fundamentals2025 Institutional Moves & Community Consensus Stock Picks - khodrobank.com
Tools to assess Pacira BioSciences Inc.’s risk profileMarket Growth Report & Comprehensive Market Scan Reports - Newser
Will Pacira BioSciences Inc. rebound enough to break evenJuly 2025 Snapshot & High Accuracy Trade Alerts - Newser
Published on: 2025-09-02 23:10:17 - Newser
Using flow based indicators on Pacira BioSciences Inc.Weekly Trade Recap & Precise Trade Entry Recommendations - Newser
Is Pacira BioSciences Inc. subject to activist investor interestPortfolio Update Report & Daily Entry Point Alerts - khodrobank.com
Is Pacira BioSciences Inc. a strong growth stock2025 Volume Leaders & High Yield Equity Trading Tips - khodrobank.com
Technical signs of recovery in Pacira BioSciences Inc.Recession Risk & Safe Capital Investment Plans - Newser
Risk vs reward if holding onto Pacira BioSciences Inc.Weekly Gains Report & Community Verified Trade Alerts - Newser
Is Pacira BioSciences Inc. stock a value trapJuly 2025 Recap & Low Risk High Win Rate Picks - khodrobank.com
Pacira BioSciences Rises 0.07% on Strong Earnings - AInvest
Why is Pacira BioSciences Inc. stock going downJuly 2025 Earnings & Weekly High Potential Stock Alerts - khodrobank.com
Can Pacira BioSciences Inc. disrupt its industry2025 Dividend Review & Breakout Confirmation Alerts - khodrobank.com
Is Pacira BioSciences Inc. a turnaround storyPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - khodrobank.com
Pacira BioSciences Inc. stock trend forecastJuly 2025 Selloffs & Verified Trade Idea Suggestions - Newser
Risk adjusted return profile for Pacira BioSciences Inc. analyzedQuarterly Earnings Report & Safe Capital Growth Stock Tips - Newser
Measuring Pacira BioSciences Inc.’s beta against major indicesPortfolio Growth Summary & Real-Time Market Trend Scan - Newser
How does Pacira BioSciences Inc. score in quality rankings2025 Top Gainers & Safe Entry Trade Reports - khodrobank.com
Institutional scanner results for Pacira BioSciences Inc.July 2025 Fed Impact & Fast Gain Swing Trade Alerts - Newser
Pacira BioSciences Inc. Included in Top Momentum ScanJuly 2025 News Drivers & Weekly Top Gainers Trade List - beatles.ru
Detecting price anomalies in Pacira BioSciences Inc. with AIMarket Risk Report & Smart Allocation Stock Tips - Newser
Automated trading signals detected on Pacira BioSciences Inc.Earnings Performance Report & Weekly Stock Performance Updates - Newser
Real time scanner hits for Pacira BioSciences Inc. explainedMarket Sentiment Review & Weekly High Conviction Trade Ideas - Newser
Best data tools to analyze Pacira BioSciences Inc. stockWeekly Stock Recap & Weekly Breakout Watchlists - Newser
Published on: 2025-08-31 02:11:49 - Newser
Price Reversal in Pacira BioSciences Inc. Traders Watch Closely getLinesFromResByArray error: size == 0 - 더경남뉴스
Pacira Biosciences Inc Azioni (PCRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pacira Biosciences Inc Azioni (PCRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BIGAL MARCELO | Director |
Aug 07 '25 |
Sale |
23.67 |
4,912 |
116,267 |
11,393 |
3.60%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):